{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:29:07Z","timestamp":1790908147943,"version":"4.1.0"},"reference-count":14,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":8606,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1985,10]]},"abstract":"<jats:p>178 episodes of essential thrombocytosis with symptoms of haemorrhage or thrombosis, were treated in 15 patients with melphalan (5 mg\/m<jats:sup>2<\/jats:sup> orally during 4 d). An average reduction in the platelet count of 77% was achieved by oral melphalan in 14 responding patients. 1 patient appeared to be refractory to oral therapy, but a decrease of the thrombocyte count was achieved after intravenous administration of melphalan. All responding patients experienced a relief of the thrombocytosis\u2010associated clinical symptoms. Reduction of the thrombocyte count persisted for 3\u20134 wk.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1985.tb02270.x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T19:25:56Z","timestamp":1280949956000},"page":"448-450","source":"Crossref","is-referenced-by-count":11,"title":["Intermittent melphalan in the treatment of essential thrombocytosis with haemorrhage or thrombosis"],"prefix":"10.1111","volume":"35","author":[{"given":"B. E.","family":"de Pauw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N. L.","family":"van Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Haanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb01900.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92098-6"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-88-1-7"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1974.tb00262.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1055\/s-0038-1651925","article-title":"The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis","volume":"38","author":"Walsh PN","year":"1977","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_7_2","first-page":"573A","article-title":"Influence of therapy on causes of death in polycythemia vera","volume":"29","author":"Wasserman LR","year":"1981","journal-title":"Clin Res"},{"key":"e_1_2_1_8_2","first-page":"1495","article-title":"Essential thrombocythemia: response during first year of therapy with melphalan and radioactive phosphorus: A Polycythemia Vera Study group report","volume":"66","author":"Murphy S.","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood.V36.1.61.61","article-title":"Hemorrhagic thrombocythemia: control of postsplenectomy thrombosis with melphalan","volume":"36","author":"Bensinger TA","year":"1970","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000131327"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1040830218"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.1.1.1"},{"key":"e_1_2_1_13_2","first-page":"1395","article-title":"Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis recurrent painful toes and fingers","volume":"2","author":"Vreeken J.","year":"1971","journal-title":"Lancet"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-99-4-513"},{"key":"e_1_2_1_15_2","first-page":"124","article-title":"Comparative pharmacokinetics of chlorambucil and melphalan in man","volume":"74","author":"Alberts DS","year":"1980","journal-title":"Cancer Res"}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1985.tb02270.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1985.tb02270.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T20:23:48Z","timestamp":1697833428000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1985.tb02270.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,10]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985,10]]}},"alternative-id":["10.1111\/j.1600-0609.1985.tb02270.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1985.tb02270.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1985,10]]}}}